Overtreatment of Low-Grade Ductal Carcinoma in Situ

JAMA Oncology - United States
doi 10.1001/jamaoncol.2015.5026
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Medical Association (AMA)

Related search

Estrogen Receptor and Cytokeratin 5 Are Reliable Markers to Separate Usual Ductal Hyperplasia From Atypical Ductal Hyperplasia and Low-Grade Ductal Carcinoma in Situ

Archives of Pathology and Laboratory Medicine
MedicineForensic MedicinePathologyMedical Laboratory Technology
2016English

Breast Ductal Carcinoma in Situ

International Journal of Surgical Oncology
SurgeryOncology
2012English

Epidemiology of Ductal Carcinoma in Situ

Journal of the National Cancer Institute. Monographs
MedicineCancer ResearchOncology
2010English

Ductal Carcinoma in Situ (DCIS)

European Journal of Cancer
Cancer ResearchOncology
2002English

Atypical Ductal Hyperplasia Bordering on Ductal Carcinoma in Situ

International Journal of Surgical Pathology
AnatomyForensic MedicinePathologySurgery
2016English

Ductal Carcinoma in Situ of the Breast

Mayo Clinic Proceedings
Medicine
2017English

Ductal Carcinoma in Situ of the Breast

New England Journal of Medicine
Medicine
2004English

Ductal Carcinoma in Situ of the Breast

Oncology Reviews
Cancer ResearchOncology
2009English

Ductal Carcinoma in Situ of the Breast

British Journal of Surgery
Surgery
1997English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy